StonvexLoading…
StonvexCore line items from HLT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $12.04B | $11.17B | $10.23B | $8.77B |
Operating Income | $2.69B | $2.37B | $2.23B | $2.09B |
Net Income | $1.46B | $1.53B | $1.14B | $1.25B |
EPS (Diluted) | $6.12 | $6.14 | $4.33 | $4.53 |
Total Assets | $16.77B | $16.52B | $15.40B | $15.51B |
Total Liabilities | $22.12B | $20.21B | $17.75B | $16.61B |
Cash & Equivalents | $918.00M | $1.30B | $800.00M | $1.21B |
Free Cash Flow OCF − CapEx | $2.03B | $1.92B | $1.79B | $1.64B |
Shares Outstanding | 230.43M | 241.81M | 253.49M | 267.86M |